Catherine Conaty

Catherine Conaty has extensive experience in financial roles, particularly as a Chief Financial Officer. Catherine most recently served as the Chief Financial Officer at ElectraMet™ since August 2021. Prior to that, they provided fractional and Interim CFO services at C&A ASSOCIATES, focusing on emerging high growth companies in the Technology, Life Sciences, and SaaS industries.

Catherine also served as the Chief Financial Officer at Astronomer from July 2019 to August 2021 and at Halo Health from May 2017 to June 2019. At Halo Health, they partnered with the Founder/CEO in raising venture funding and closed multiple contracts with customers and vendors.

Other notable roles include serving as Vice President Finance at Putney, Inc. from November 2014 to May 2016, Senior Director of Finance & Systems at Sirrus, Inc. from 2011 to November 2014, and Financial Consultant at Veelo Technologies from 2011 to 2014. Catherine was also a Financial Consultant at Blue Ash Therapeutics, LLC from 2010 to 2011.

Earlier in their career, Catherine served as the Chief Financial Officer at NOVUS Communication Technologies Inc/NOVUS Partners LLC from 2002 to 2009 and held various finance and operations roles at Johnson & Johnson, including Finance Manager, Manager Operations, and Controller, from 1995 to 2002.

Overall, Catherine Conaty brings a wealth of experience in finance and has a strong track record in raising capital, developing financial systems, and managing financial operations in various industries.

Catherine Conaty's education history includes a Master of Business Administration (MBA) degree in Finance and Management from Bryant University. In 1997, they completed a program on New Product Development and Disruptive Technologies at Harvard Business School Executive Education. Catherine also holds a Bachelor of Science (BS) degree in Accounting and Management from the University of Rhode Island - College of Business.

No information is provided about any certifications Catherine Conaty may have obtained.